[Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)]
[Notices]
[Pages 27768-27769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13222]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Neurological Devices Panel of the Medical
Devices Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA regulatory issues.
Date and Time: The meeting will be held on June 27, 1997, 9:30 a.m.
to 3:30 p.m.
Location: Corporate Bldg., conference room 020B, 9200 Corporate
Blvd., Rockville, MD.
Contact Person: G. Levering Keely, Center for Devices and
Radiological Health (HFZ-450), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850, 301-443-8517, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 12513. Please call the Information Line for
up-to-date information on this meeting.
Agenda: The committee will discuss and vote on a premarket approval
application for an implanted stimulator, as an adjunct to drugs, for
reducing the frequency of partial onset seizures in adults and
adolescents over 12 years of age.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by June 13, 1997.
Oral presentations from the public will be scheduled between
approximately 9:30 a.m. to 10:30 a.m. Time allotted for each
presentation may be limited. Those
[[Page 27769]]
desiring to make formal oral presentations should notify the contact
person before June 13, 1997, and submit a brief statement of the
general nature of the evidence or arguments they wish to present, the
names and addresses of proposed participants, and an indication of the
approximate time requested to make their presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: May 13, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-13222 Filed 5-20-97; 8:45 am]
BILLING CODE 4160-01-F
